Profile

PlantForm develops and manufactures proteins, antibodies, and vaccines at extremely low cost using a green, plant-based, production system. PlantForm’s vivoXPRESS® expression system opens opportunities to produce its own, its partners’, and its contract customers’ products at competitive prices. A risk-mitigated pipeline of biosimilars and biodefence drugs, combined with strong IP, makes the company attractive to investors.  PlantForm is seeking biosimilar drug partnerships, contract customers, and investors in a Series A financing.


Event details

Date: June 5 - 8, 2023

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

33 in total